Startup India Government of India
Clinimed Allergy Solutions Private Limited
Clinimed Allergy Solutions Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹31.5 Lakh
▲ 343% YoY
Net loss · FY 2024
₹15.86 Lakh
Net margin -50.3%
EBITDA · FY 2024
-₹18.38 Lakh
EBITDA margin -58.3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹79.5 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Clinimed Allergy Solutions Private Limited
Data last updated:
Clinimed Allergy Solutions Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24299KA2021PTC146067. Its GSTIN is 29AAJCC4009K1ZH (Karnataka).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹79.5 Lakh. It is led by directors Gururaj Rao Pejavar and Asha Gururaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.5 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹15.86 Lakh (net margin -50.3%) and EBITDA of -₹18.38 Lakh (EBITDA margin -58.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24299KA2021PTC146067
Registration Number 146067
Incorporation Date 01 April 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Clinimed Allergy Solutions
Contact details
Clinimed Allergy Solutions Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressShed No. A – 157 3rd Cross, 1st Stage, Bangalore, Karnataka, India – 560058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Clinimed Allergy Solutions Private Limited, buy the company report.
Comprehensive company report
Clinimed Allergy Solutions Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Clinimed Allergy Solutions is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Clinimed Allergy Solutions Private Limited, buy the company report.
Financials of Clinimed Allergy Solutions Private Limited
FY 2025 filings availableClinimed Allergy Solutions Private Limited reported revenue of ₹31.5 Lakh (up 343% YoY) for FY 2024.
Revenue · FY 2024
₹31.5 Lakh ▲ 343%
Net loss · FY 2024
₹15.86 Lakh margin -50.3%
EBITDA · FY 2024
-₹18.38 Lakh margin -58.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 343%
Revenue rose 343% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹18.38 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹15.86 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -58.3% | ||
| Net Profit Margin | -50.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Clinimed Allergy Solutions Private Limited, buy the company report.
Board of directors of Clinimed Allergy Solutions Private Limited
Clinimed Allergy Solutions has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gururaj Rao Pejavar | Director | 01 Apr 2021 | 5 Years 7 Months | Current |
| Asha Gururaj Also directs: Clinical Sleep and Respiratory Solutions Private Limited | Director | 01 Apr 2021 | 5 Years 7 Months | Current |
Auditor
Clinimed Allergy Solutions Private Limited is audited by Sharath & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sharath & Co. | FY 2023 | 003782S |
Shareholding
The shareholding of Clinimed Allergy Solutions Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Clinimed Allergy Solutions Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Clinimed Allergy Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clinimed Allergy Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Clinimed Allergy Solutions Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
Clinimed Allergy Solutions has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAJCC4009K1ZH | Karnataka | Active | 11 Nov 2021 |
To see the full GST registrations and return filing status of Clinimed Allergy Solutions Private Limited, buy the company report.
Recent activity
Clinimed Allergy Solutions Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Asha Gururaj was appointed as Director on 01 Apr 2021.
AGM
Clinimed Allergy Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Clinimed Allergy Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Asha Gururaj was appointed as Director.
Appointed
Gururaj Rao Pejavar was appointed as Director.
Incorporation
01 Apr 2021
Clinimed Allergy Solutions Private Limited was registered on 01 Apr 2021 with Roc Bangalore & aged 5 years 7 months as per MCA records.
Frequently asked questions
Clinimed Allergy Solutions is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 April 2021 (5+ years old) and is registered under CIN U24299KA2021PTC146067.
Clinimed Allergy Solutions has 2 current directors:
- Gururaj Rao Pejavar - Director
- Asha Gururaj - Director
The latest financial statements of Clinimed Allergy Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Clinimed Allergy Solutions is 29AAJCC4009K1ZH, registered in Karnataka.
The CIN (Corporate Identification Number) of Clinimed Allergy Solutions is U24299KA2021PTC146067. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clinimed Allergy Solutions was incorporated on 01 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Asha Gururaj was appointed as Director on 01 Apr 2021. Gururaj Rao Pejavar was appointed as Director on 01 Apr 2021.
Yes, Clinimed Allergy Solutions is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Clinimed Allergy Solutions is at Shed No. A – 157 3rd Cross, 1st Stage, Bangalore, Karnataka, India – 560058.
Clinimed Allergy Solutions operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages